The Department of Veterans Affairs issued a Sources Sought Notice (Solicitation No. 36C25725Q0240) seeking information on providers capable of delivering Inhaled Nitric Oxide Therapy services at the South Texas VA Health Care System. This request aims to identify potential sources for a pharmaceutical drug, delivery devices, training, and maintenance services related to nitric oxide therapy, governed by NAICS Code 325412. Responses from businesses are encouraged, particularly from Service-Disabled Veteran-Owned, Veteran-Owned, HUBZone, and Woman-Owned Small Businesses. Interested parties must provide company classification, capabilities, and whether they are manufacturers or distributors of the required items. The contract for these services is anticipated to include installation, testing of equipment, and adherence to both VA specifications and federal laws, while ensuring patient safety and compliance with the Buy American Act. The firms responding must demonstrate their ability to meet identified specifications and should be prepared for audits of their compliance with the contract terms. In essence, this notice serves as a preliminary inquiry to gauge market capabilities before potentially moving forward with a formal solicitation, emphasizing the need for quality and compliance in therapy services critical to patient care within the VA system.

The Inhale Nitrate Therapy Services document outlines a contract for providing and installing a PSG Channel System, Software, and accessories at the South Texas VA Health Care System. The contractor is responsible for transporting, installing, and testing all equipment, ensuring compliance with VA specifications and addressing any missing components. The agreement includes the provision of nitric oxide for inhalation, a delivery device, maintenance items, and training services. It emphasizes the contractor's warranty, maintenance obligations, safety protocols, and customer responsibilities for system operation and environmental compliance. Key terms cover ownership retention by the contractor, invoicing and payment terms, audit rights, and compliance with federal laws such as the Food and Drug Act. Privacy considerations mandate that contractors do not access patient health information, and all data produced is owned by the government. This structured and detailed service description reflects the government’s commitment to ensuring safe, effective therapy delivery in critical care settings while maintaining adherence to regulations and accountability in operational practices.